Status:
UNKNOWN
COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study
Lead Sponsor:
University College, London
Collaborating Sponsors:
Newcastle-upon-Tyne Hospitals NHS Trust
Sheffield Teaching Hospitals NHS Foundation Trust
Conditions:
COV-HI
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Based on emerging experience and trials from countries affected early by the COVID-19 (COV19) pandemic, there is evidence that a subgroup of severely affected people develop a hyperinflammatory (HI) s...
Detailed Description
Early information from the UK ICNARC (Intensive Care National Audit and Research Centre)- COVID-19 Study Case Mix Programme Database 27 March 2020 report that critical care unit admissions with COVID-...
Eligibility Criteria
Inclusion
- \- Adults (18 years and over) admitted to hospital who are COVID-19 positive (PCR positive on a swab, through routine clinical laboratory testing)
Exclusion
- \- No exclusion criteria
Key Trial Info
Start Date :
April 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 5 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04385069
Start Date
April 16 2020
End Date
July 5 2020
Last Update
May 12 2020
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
The Leeds Teaching Hospitals NHS Trust, St James University Hospital
Leeds, United Kingdom, LS9 7TF
2
University College London Hospitals NHS Foundation Trust
London, United Kingdom, NW1 2BU
3
The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital
Newcastle upon Tyne, United Kingdom, NE7 7DN
4
Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom, NG7 2UH